Abstract
Stem Cell Factor (SCF) is generally thought to be an important regulator of melanocyte and mast cell survival, migration and proliferation. The c-kit receptor (CD117) may play a role in many skin disorders with dyspigmentation. The aim of this study was to assess the immunohistochemical expression of CD117 in some pigmentary disorders such as melasma and vitiligo. The study included a total of 40 patients were divided into two groups; melasma group: included (20) patients and vitiligo group: included (20) patients, in addition to a control group which included (20) healthy skin specimens were obtained during plastic operations. The severity of melasma and vitiligo skin lesions was measured by modified melasma and area severity index (MASI) and vitiligo area severity index (VASI) scores respectively. Tissue biopsies were taken from all the participant and stained by haematoxylin and eosin (H and E) and immunohistochemical staining for c-kit antibody. Normal skin: The intensity of c-kit expression was mild to moderate positivity Melasma: The intensity of c-kit expression showed significant increase when its expression was compared with control group. There was statistically significant positive correlation between the intensity of c-kit expression in both melasma groups when compared with modified MASI score Vitiligo: c-kit expression was negative in the epidermis. There was significant decrease in the intensity of c-kit expression in vitiligo when compared with control group. There was statistically significant negative correlation between the intensity of c-kit expression in both vitiligo groups when compared with VASI score we concluded that c-kit may play a role in the pathogenesis of some dyspigmentary disorders as melasma and vitiligo. It could be used as a marker for melasma severity. So, c-kit is may be considered the main target in the treatment of these diseases.
Highlights
CD117 (c-kit) is a transmembrane receptor tyrosine kinase that binds stem cell factor (SCF) [1]. c-kit is encoded by the kit proto-oncogene, localized to human chromosome 4 and to mouse chromosome 5 [2]
It has been reported that paracrine linkages among keratinocytes, fibroblasts and melanocytes within the skin play important roles in regulating epidermal melanization in response to various stimuli [8,9,10]
Lesional melasma skin showed more prominent solar elastosis compared with normal skin, suggesting that melasma may develop by activation of melanocytes overlying dermal changes caused by solar radiation [12,13]
Summary
CD117 (c-kit) is a transmembrane receptor tyrosine kinase that binds stem cell factor (SCF) [1]. c-kit is encoded by the kit proto-oncogene, localized to human chromosome 4 and to mouse chromosome 5 [2]. The c-kit/SCF interaction is critical for the survival and development of stem cells involved in hematopoiesis in pancreas development and in melanogenesis [3,4,5]. It has been reported that paracrine linkages among keratinocytes, fibroblasts and melanocytes within the skin play important roles in regulating epidermal melanization in response to various stimuli [8,9,10]. The upregulation of such networks is intrinsically involved in the stimulation of melanocyte function in vivo in several epidermal hyperpigmentary disorders [11]. Lesional melasma skin showed more prominent solar elastosis compared with normal skin, suggesting that melasma may develop by activation of melanocytes overlying dermal changes caused by solar radiation [12,13]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of Clinical & Experimental Dermatology Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.